5059-36-9,
1-[2-(2,5-dimethyl-1H-pyrrol-1-yl)ethyl]piperazine,
1-(2-(2,5-Dimethyl-1H-pyrrol-1-yl)ethyl)piperazine,
1-[2-(2,5-Dimethyl-pyrrol-1-yl)-ethyl]-piperazine,
NSC62606,
1-[2-(2,5-dimethylpyrrol-1-yl)ethyl]piperazine,
Piperazine,1-[2-(2,5-dimethyl-1H-pyrrol-1-yl)ethyl]-,
[2-(2,5-dimethylpyrrolyl)ethyl]piperazine,
NSC 62606,
Enamine_004518,
AC1L6KOH,
AC1Q2JKO,
NCIOpen2_002810,
Oprea1_262934,
Oprea1_642900,
AC1Q4V47,
SCHEMBL2109268,
CTK4J2835,
DTXSID00198618,
AUSXFRFXXDHSTC-UHFFFAOYSA-N,
HMS1406N08,
ALBB-006838,
KS-00002A6R,
4467AE,
BBL029959,
MFCD03407319,
NSC-62606,
SBB010142,
STK500376,
ZINC19229989,
AKOS000117887,
CCG-144369,
MCULE-1509533845,
PS-4427,
SDCCGMLS-0066166.P001,
VP70185,
BAS 06100963,
TR-042573,
BB 0219189,
FT-0607088,
R6786,
ST50037133,
EN300-12894,
I14-99698,
Z56865050,
Piperazine, 1-[2-(2,5-dimethyl-1H-pyrrol-1-yl)ethyl]-,
1-[2-(2,5-dimethyl-1H-pyrrol-1-yl)ethyl]piperazine, AldrichCPR,
1-[2- ETHYL]PIPERAZINE,
KST-1B5333,
C12H21N3,
AR-1B8917,
CID247631,
5452-60-8,